NeuroTherm moves into vertebroplasty by purchasing ArthroCare product lines
This article was originally published in Clinica
Executive Summary
Chronic pain treatment firm NeuroTherm is expanding into the spinal surgery market by acquiring two product lines from minimally-invasive surgery specialist ArthroCare. The first, Parallax, is used during vertebroplasty, a procedure where bone cement is injected into the vertebra to relieve the pain of spinal fractures. ArthroCare acquired the product with its $28m purchase of spinal company Parallax in 2004 (www.clinica.co.uk, 31 October 2003). The second product, Contour, is designed for cavity creation, a step in the vertebroplasty process.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.